Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
RESEARCH TOOLSreports
Holding NAMS?
Track your performance easily
NewAmsterdam Pharma Company (NAMS) Ownership Overview
8.50% Insiders
1.12% Mutual Funds
3.81% Other Institutional Investors
0.16% ETFs
86.41% Public Companies and
Individual Investors
The ownership structure of NewAmsterdam Pharma Company (NAMS) stock is a mix of institutional, retail, and individual investors. Approximately 5.09% of the company’s stock is owned by Institutional Investors, 8.50% is owned by Insiders, and 86.41% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 01, 2024 | xxxxxxxxxxxxx | $707400 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $17333 | |
| Aug 22, 2024 | Michael H. Davidson Ceo,director | xxxxxxxxxxxxx | $81350 |
| Jun 24, 2024 | Michael H. Davidson Ceo,director | xxxxxxxxxxxxx | $86300 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $468435 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $9285883 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $16698292 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $17132169 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,064,000 | Institution | 8.96% | 154,425,600 | |
| 8,024,565 | Institution | 8.91% | 153,670,420 | |
| 6,809,429 | Insider | 7.56% | 130,400,565 | |
| 891,836 | Institution | 0.99% | 17,078,659 | |
| 869,250 | Institution | 0.97% | 16,646,138 | |
| 818,563 | Insider | 0.91% | 15,675,481 | |
| 489,125 | Institution | 0.54% | 9,366,744 | |
| 483,388 | Institution | 0.54% | 9,256,880 | |
| 330,200 | Institution | 0.37% | 6,323,330 | |
| 175,000 | Institution | 0.19% | 3,351,250 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 489,125 | Institution | 0.54% | 9,366,744 | |
| 330,200 | Institution | 0.37% | 6,323,330 | |
| 80,436 | Institution | 0.09% | 1,540,349 | |
| 53,744 | Institution | 0.06% | 1,029,198 | |
| 29,290 | Institution | 0.03% | 560,904 | |
| 20,570 | Institution | 0.02% | 393,916 | |
| 9,300 | Institution | 0.01% | 178,095 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 70,802 | Institution | 0.08% | 1,276,560 | |
| 32,610 | Institution | 0.04% | 541,326 | |
| 23,443 | Institution | 0.03% | 417,754 | |
| 8,136 | Institution | <0.01% | 144,984 | |
| 4,738 | Institution | <0.01% | 85,426 | |
| 1,246 | Institution | <0.01% | 22,465 | |
| 158 | Institution | <0.01% | 2,816 |
FAQ
Who Owns NewAmsterdam Pharma Company (NAMS)?
According to the latest TipRanks data, approximately 3.81% of the company's stock is held by institutional investors, 8.50% is held by insiders, and 86.41% is held by retail investors.
What percentage of NewAmsterdam Pharma Company (NAMS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.81% of NewAmsterdam Pharma Company (NAMS) stock is held by institutional investors.
What percentage of NewAmsterdam Pharma Company (NAMS) stock is held by retail investors?
According to the latest TipRanks data, approximately 86.41% of NewAmsterdam Pharma Company (NAMS) stock is held by retail investors.
Who owns the most shares of NewAmsterdam Pharma Company (NAMS)?
Peter Kolchinsky owns the most shares of NewAmsterdam Pharma Company (NAMS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.